Wed, May 29, 2019
Tue, May 28, 2019
Fri, May 24, 2019
Thu, May 23, 2019
Wed, May 22, 2019
Tue, May 21, 2019

Terence Flynn Initiated (BPMC) at Strong Buy and Held Target at $125 on, May 23rd, 2019

Terence Flynn of Goldman Sachs, Initiated "Blueprint Medicines Corporation" (BPMC) at Strong Buy and Held Target at $125 on, May 23rd, 2019.

Terence has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with Terence's Rating of Hold.



This is the rating of the analyst that currently disagrees with Terence


  • Andrew Berens of "Morgan Stanley" Initiated at Buy and Held Target at $112 on, Wednesday, April 3rd, 2019